SCHEMBL7664633

SCHEMBL7664633

CC(C)CC(NC1CCCCC1)C(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 3/20 0.48
CNR2 P34972 3/20 0.48
HTT P42858 2/20 0.47
NPSR1 Q6W5P4 2/20 0.47
CACNA1B Q00975 2/20 0.46
ACHE P22303 2/20 0.45
GAA P10253 1/20 0.45
CACNA2D1 P54289 1/20 0.45
CACNB1 Q02641 1/20 0.45
CACNA1C Q13936 1/20 0.45
LMNA P02545 1/20 0.44
TSHR P16473 1/20 0.44
KMT2A Q03164 1/20 0.44
DPP8 Q6V1X1 2/20 0.43
DPP4 P27487 1/20 0.43
DPP9 Q86TI2 1/20 0.43
FAAH O00519 1/20 0.43
MGLL Q99685 1/20 0.43
DPP7 Q9UHL4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7664625 1.00 CNR1 (0.48) CNR1CNR2HTTNPSR1CACNA1B
SCHEMBL7661393 0.90 ACHE (0.48) NPSR1CACNA1BACHECACNA2D1CACNB1
SCHEMBL7425357 0.90 ACHE (0.48) NPSR1CACNA1BACHECACNA2D1CACNB1
SCHEMBL7661270 0.87 CNR1 (0.47) CNR1CNR2CACNA1BACHECACNA2D1
SCHEMBL7391183 0.87 CNR1 (0.47) CNR1CNR2CACNA1BACHECACNA2D1
SCHEMBL7664035 0.85 CACNA2D1 (0.49) CACNA1BACHECACNA2D1CACNB1CACNA1C
SCHEMBL7390924 0.85 CACNA2D1 (0.49) CACNA1BACHECACNA2D1CACNB1CACNA1C
Hydrochloric Acid SCHEMBL7653866 0.84 CACNA1B (0.48) CACNA1BACHECACNA2D1CACNB1CACNA1C
Hydrochloric Acid SCHEMBL7653878 0.84 CACNA1B (0.48) CACNA1BACHECACNA2D1CACNB1CACNA1C
SCHEMBL7428289 0.83 CNR1 (0.54) CNR1CNR2HTTNPSR1CACNA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458781-B1 BLOCKERS CALCIUM CHANNEL ANTAGONISTS FOR STROKES, BRAIN DISORDERS WARNER-LAMBERT COMPANY 2002-10-01 US disclosed